Natco Pharma gets USFDA nod for tablets used for treating high blood pressure in lungs

Share it

The tablets in the strength of 32mg are the generic version of Tracleer, developed by Actelion Pharmaceuticals US Inc, Natco Pharma said in a stock exchange filing.

Leave a Comment

Your email address will not be published. Required fields are marked *